Keunchil D. Park
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 437 publications
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study.
Journal: Targeted oncology
Published: September 02, 2025
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 17, 2025
Emerging options and future strategies in immunotherapy for advanced lung squamous-cell carcinoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 04, 2025
Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 21, 2025
Intracranial and systemic progression on amivantamab in platinum-treated epidermal growth factor receptor exon 20 insertion-mutated advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 21, 2025
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions.
Journal: Nature reviews. Clinical oncology
Published: December 06, 2024
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 09, 2024
Plain language summary of PAPILLON: amivantamab plus chemotherapy in untreated EGFR-mutated non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: July 16, 2024
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 03, 2024
The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.
Journal: Cancer research and treatment
Published: April 30, 2024
A brief report on stable disease among amivantamab-treated patients with post-platinum epidermal growth factor receptor exon 20 insertion-mutated non-small cell lung cancer: A response-based analysis from the CHRYSALIS study.
Journal: Cancer treatment and research communications
Published: March 04, 2024
Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non-Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.
Journal: Cancer research and treatment
Published: January 23, 2024
Last Updated: 09/26/2026